Susi Varvayanis

Susi Varvayanis

Auto-generated profile, based on publicly available information

Susi Varvayanis

Cornell University Graduate School, Ithaca, NY, United States of America

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 1986 in Science
Verified
Journal Article
Closed access
PDF file
SSS. Zaki Salahuddin
S. Zaki Salahuddin
DADharam V. Ablashi
Dharam V. Ablashi
PMPhillip D. Markham
Phillip D. Markham
SJSteven F. Josephs
Steven F. Josephs
SSSusi Sturzenegger
Susi Sturzenegger
RGRobert C. Gallo
Robert C. Gallo
A novel human B-lymphotropic virus (HBLV) was isolated from the peripheral blood leukocytes of six individuals: two HTLV-III seropositive patients from the United States (one with AIDS-related lymphoma and one with dermatopathic lymphadenopathy), three HTLV-III seronegative patients from the United States (one with angioimmunoblastic lymphadenopathy, one with cutaneous T-cell lymphoma, and one with immunoblastic lymphoma), and one HTLV-III seronegative patient with acute lymphocytic leukemia from Jamaica. All six isolates were closely related by antigenic analysis, and sera from all six virus-positive patients reacted immunologically with each virus isolate. In contrast, only four sera from 220 randomly selected healthy donors and none from 12 AIDS patients without associated lymphoma were seropositive. The virus selectively infected freshly isolated human B cells and converted them into large, refractile mono- or binucleated cells with nuclear and cytoplasmic inclusion bodies. HBLV is morphologically similar to viruses of the herpesvirus family but is readily distinguishable from the known human and nonhuman primate herpesviruses by host range, in vitro biological effects, and antigenic features.

15 February 1987 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
SSS. Z. Salahuddin
S. Z. Salahuddin
EHE. A. Hunter
E. A. Hunter
SSS. Sturzenegger
S. Sturzenegger
PMP. D. Markham
P. D. Markham
RGR. C. Gallo
R. C. Gallo
MGM. A. Gonda
M. A. Gonda

1 October 1999 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
AYAndrew Yen
Andrew Yen
MRMark S. Roberson
Mark S. Roberson
SVSusi Varvayanis
Susi Varvayanis

2 December 2005 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
TLThomas J. Lamkin
Thomas J. Lamkin
VCVivian Chin
Vivian Chin
SVSusi Varvayanis
Susi Varvayanis
JSJames L. Smith
James L. Smith
RSR. Michael Sramkoski
R. Michael Sramkoski
AYAndrew Yen
Andrew Yen

1 August 2001 in Differentiation
Verified
Journal Article
Closed access
PDF file
HHHee-Youn Hong
Hee-Youn Hong
SVSusi Varvayanis
Susi Varvayanis
AYAndrew Yen
Andrew Yen

1 September 1994 in Experimental Cell Research
Verified
Journal Article
Open access
AYAndrew Yen
Andrew Yen
SVSusi Varvayanis
Susi Varvayanis
The cell cycle phase-specific phosphorylation status of the RB protein (retinoblastoma tumor suppressor gene product) during an elicited cellular program of G0 arrest and cell differentiation was characterized. The RB protein phosphorylation state is presumed to be an important determinant of cell proliferation or arrest. The cell cycle phase specificity of RB protein phosphorylation and dephosphorylation during HL-60 human leukemia cell proliferation and differentiation was determined using DNA-based fluorescence-activated cell sorting and Western analysis. The RB protein in proliferating G1 cells was phosphorylated, but at a relatively low level. The extent of phosphorylation increased in S phase cells and was maximum in G2 + M cells. After the cells were treated with retinoic acid or 1,25-dihydroxy vitamin D3, they began to accumulate in G1/0 and phenotypically convert. Significant unphosphorylated RB protein did not appear until after the first cells had arrested and differentiated. Dephosphorylation of the RB protein was first apparent at the beginning of G2 in the remaining cycling cells after onset of arrest and differentiation had already occurred. By the time the remaining cycling cells had divided and arrested, resulting in G0 cells, a majority of RB protein was dephosphorylated, but some remained phosphorylated. The data indicate that dephosphorylation of RB does not determine residence in G1/0. Rather dephosphorylation appears as one relatively late-occurring component of the metabolic cascade culminating in G0-arrested, phenotypically differentiated cells. Dephosphorylated RB appears as a feature of differentiated cells. The data are consistent with a role for hypophosphorylated RB not so much in deriving, but in possibly sustaining the differentiated state.